Overview
Agneta Wikman practices in Stockholm, Sweden. Ms. Wikman is highly rated in 4 conditions, according to our data. Her top areas of expertise are Fetal and Neonatal Alloimmune Thrombocytopenia, Hemolytic Transfusion Reaction, Hemolytic Disease of the Newborn, Bone Marrow Transplant, and Pancreas Transplant.
Her clinical research consists of co-authoring 107 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Stockholm, AB, Sweden
Huddinge, AB, Sweden
Karolinska Institutet, Sweden
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Advanced
- Hemolytic Disease of the NewbornMs. Wikman isAdvanced. Learn about Hemolytic Disease of the Newborn.
- Hemolytic Transfusion ReactionMs. Wikman isAdvanced. Learn about Hemolytic Transfusion Reaction.
- ThrombocytopeniaMs. Wikman isAdvanced. Learn about Thrombocytopenia.
- Experienced
- ABO IncompatibilityMs. Wikman isExperienced. Learn about ABO Incompatibility.
- Alpha ThalassemiaMs. Wikman isExperienced. Learn about Alpha Thalassemia.
- AnemiaMs. Wikman isExperienced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaMs. Wikman isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Bone Marrow TransplantMs. Wikman isExperienced. Learn about Bone Marrow Transplant.
- COVID-19Ms. Wikman isExperienced. Learn about COVID-19.